These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18652548)

  • 21. Seasonal influenza vaccines: evolutions and future trends.
    Monto AS; Ohmit SE
    Expert Rev Vaccines; 2009 Apr; 8(4):383-9. PubMed ID: 19348555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The elderly profit from adjuvanated influenza vaccines].
    MMW Fortschr Med; 2006 Nov; 148(46):54-5. PubMed ID: 17615792
    [No Abstract]   [Full Text] [Related]  

  • 23. WHO meeting on the role of neuraminidase in inducing protective immunity against influenza infection, Vilamoura, Portugal, September 14, 2008.
    Bright RA; Neuzil KM; Pervikov Y; Palkonyay L
    Vaccine; 2009 Oct; 27(45):6366-9. PubMed ID: 19840675
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccinate schoolchildren to reduce influenza toll.
    Ross G
    Arch Intern Med; 2005 Sep; 165(17):2038; author reply 2039-40. PubMed ID: 16186479
    [No Abstract]   [Full Text] [Related]  

  • 25. How to win trust over flu.
    Nature; 2009 Oct; 461(7265):698. PubMed ID: 19812628
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
    King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
    Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A trial of an influenza vaccine in miners.
    Joosting AC; Harwin RM; Sweetnam B; Orchard M; Martin E; Lowe JP; Oberholzer D
    S Afr J Med Sci; 1971 Jul; 36(1):33-7. PubMed ID: 5135413
    [No Abstract]   [Full Text] [Related]  

  • 28. Information from your family doctor. Influenza vaccine.
    Am Fam Physician; 2003 Feb; 67(4):797-8. PubMed ID: 12613735
    [No Abstract]   [Full Text] [Related]  

  • 29. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages.
    Camilloni B; Neri M; Lepri E; Iorio AM
    Vaccine; 2009 Jun; 27(31):4099-103. PubMed ID: 19410623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NEW technologies for meeting the global demand for pandemic influenza vaccines.
    Fedson DS
    Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moving influenza vaccines forward.
    Sambhara S; Stephenson I
    Expert Rev Vaccines; 2009 Apr; 8(4):375-7. PubMed ID: 19348553
    [No Abstract]   [Full Text] [Related]  

  • 32. Influenza virus-like particle vaccines.
    Haynes JR
    Expert Rev Vaccines; 2009 Apr; 8(4):435-45. PubMed ID: 19348559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination of people at increased risk of influenza complications in Italy: how far have we gone?
    Pariani E; Amendola A; Tanzi E; Zanetti A
    Vaccine; 2009 May; 27(25-26):3342-4. PubMed ID: 19200831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.
    Scharpé J; Peetermans WE; Vanwalleghem J; Maes B; Bammens B; Claes K; Osterhaus AD; Vanrenterghem Y; Evenepoel P
    Am J Kidney Dis; 2009 Jul; 54(1):77-85. PubMed ID: 19339089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valuing influenza vaccine: medical, economic, and social benefits.
    Poland GA
    Clin Infect Dis; 2009 Feb; 48(3):299-301. PubMed ID: 19115975
    [No Abstract]   [Full Text] [Related]  

  • 37. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influenza: to vaccinate? And whom?].
    Albano A
    Recenti Prog Med; 1996 Jun; 87(6):308-9. PubMed ID: 8766960
    [No Abstract]   [Full Text] [Related]  

  • 39. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K; Fiers W; Saelens X
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.
    Goji NA; Nolan C; Hill H; Wolff M; Noah DL; Williams TB; Rowe T; Treanor JJ
    J Infect Dis; 2008 Sep; 198(5):635-41. PubMed ID: 18694338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.